Bio-Rad Launches Nuvia wPrime 2A Media for Scalable Biomolecule Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of ...

January 15, 2025 | Wednesday | News
Samsung Biologics Expands Collaboration with LigaChem Biosciences to Enhance ADC Development and Manufacturing

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced to extend collaboration with L...

January 09, 2025 | Thursday | News
Primo Biotechnology Partners with SHINE Technologies to Distribute Ilumira® in Asia-Pacific

Primo Biotechnology (“Primo”) announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader in nuclear ...

January 09, 2025 | Thursday | News
Bio-Rad Launches Foresight™ Pro 45 cm Chromatography Columns for Biopharma Applications

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of Fores...

January 08, 2025 | Wednesday | News
CG MedTech Partners with CGBIO to Host International Spine Endoscopy Training, Highlighting Korea’s Leadership in Minimally Invasive Surgery

CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered with CGBIO&nb...

January 01, 2025 | Wednesday | News
BeiGene Exercises Option for DB1312/BG-C9074, Securing Global Rights to DualityBio's B7H4 Antibody-Drug Conjugate

Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its exclusive option for the B7H4 antibody-drug conjugate (ADC) DB1312/BG-C907...

December 31, 2024 | Tuesday | News
AusperBio Therapeutics Secures $73M Series B Funding to Advance Targeted Therapies for Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

December 27, 2024 | Friday | News
FDA Approves Ionis’ TRYNGOLZA™ as the First Treatment for Familial Chylomicronemia Syndrome (FCS)

 Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (o...

December 20, 2024 | Friday | News
MSD and Hansoh Pharma Enter Exclusive Global License Agreement for Investigational GLP-1 Receptor Agonist HS-10535

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company,  announced that they ...

December 19, 2024 | Thursday | News
Novo Nordisk Commits 8.5 Billion DKK to Transformative Production Facility in Odense, Strengthening Denmark and Europe’s Biopharma Landscape

Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment mar...

December 16, 2024 | Monday | News
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025

  In a compelling conversation with BioPharma BoardRoom, Venkata Indurthi, Chief Scientific Officer at Aldevron, shares insights into the inn...

December 12, 2024 | Thursday | Interaction
Building a Sustainable Future: Cytiva’s 2025 Roadmap for Transforming Biopharma

As the biopharma industry continues to evolve, sustainability has emerged as a key driver of progress. Ryan Walker, Sustainability Program Leader at Cyt...

December 12, 2024 | Thursday | Opinion
Taiwan’s Formosa Pharmaceuticals Partners with Medvisis to Launch Innovative Ophthalmic Treatment in Switzerland and Liechtenstein

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switze...

November 29, 2024 | Friday | News
Asia’s First Modular Biomanufacturing Hub by Sanofi Sets New Global Standard for Agile Vaccine and Biomedicine Production

  The facility’s novel concept shortens production timelines and enables  rapid changes in production capacities across medicines &...

November 27, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close